030-444 practice question 6 of 35

What is the best test of cardiovascular function for a client who is obese, has claudication in the legs, and has limited mobility because of neurologic damage from uncontrolled diabetes?

Full set: 370 questions
Answer options
A: Dipyridamole or dobutamine testing and assessment of cardiovascular variables. Correct answer
B: Discontinuous treadmill exercise test.
C: Resting echocardiography.
D: Continuous submaximal cycle ergometer test.
Correct Answer:
A. Dipyridamole or dobutamine testing and assessment of cardiovascular variables.
Explanation

The client has multiple contraindications to standard exercise-based stress testing. Claudication (leg pain from peripheral artery disease) and neurologic damage limit the ability to use a treadmill or cycle ergometer. In such cases, a pharmacological stress test is the most appropriate method to assess cardiovascular function. Dipyridamole (a vasodilator) or dobutamine (an inotropic/chronotropic agent) are used to pharmacologically induce cardiac stress, mimicking the effects of exercise. This allows for assessment of cardiovascular variables (e.g., via echocardiography or nuclear imaging) in patients who cannot perform physical exercise.

Why Incorrect

B. A discontinuous treadmill test is impossible for a client with severe claudication and limited mobility who cannot walk effectively on a treadmill.
C. Resting echocardiography only provides information on cardiac structure and function at rest; it does not evaluate the heart's response to stress, which is the purpose of the test.
D. A cycle ergometer test is contraindicated by the client's claudication and neurologic damage, which would prevent effective and safe pedaling.

References

1. Riebe, D., Ehrman, J. K., Liguori, G., & Magal, M. (Eds.). (2021). ACSM's Guidelines for Exercise Testing and Prescription (11th ed.). Wolters Kluwer. (Chapter 6, "Clinical Exercise Testing and Interpretation," Box 6.2, p. 149, lists indications for pharmacologic stress testing, including ambulatory and orthopedic limitations).

2. Fletcher, G. F., Ades, P. A., Kligfield, P., Arena, R., Balady, G. J., et al. (2013). Exercise Standards for Testing and Training: A Scientific Statement From the American Heart Association. Circulation, 128(8), 873–934. (Section: "Pharmacologic Stress Testing," p. 889, states it is an alternative for patients unable to exercise). https://doi.org/10.1161/CIR.0b013e31829b5b44

3. Pellikka, P. A., Nagueh, S. F., Elhendy, A. A., Kuehl, C. A., & Sawada, S. G. (2007). American Society of Echocardiography Recommendations for Performance, Interpretation, and Application of Stress Echocardiography. Journal of the American Society of Echocardiography, 20(9), 1021-1041. (Section: "Pharmacologic Stress," p. 1024, details its use when patients cannot exercise). https://doi.org/10.1016/j.echo.2007.07.003

Scroll to Top